The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

25 articles for M Adler


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.EBI
Brookhaven National Laboratory
Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.EBI
Elan Pharmaceuticals
Triazolopyridazine LRRK2 kinase inhibitors.EBI
Elan Pharmaceuticals
Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors.EBI
Elan Pharmaceuticals
Novel cinnoline-based inhibitors of LRRK2 kinase activity.EBI
Elan Pharmaceuticals
Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA).EBI
Berlex Biosciences
1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.EBI
Berlex Biosciences
The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase.EBI
Berlex Biosciences
Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors.EBI
Berlex Biosciences
3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa).EBI
Berlex Biosciences
The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.EBI
Pfizer
Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness.EBI
University of California San Francisco
Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis.EBI
Abdulaziz University For Health Sciences
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.EBI
The Scripps Research Institute
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitorsBDB
Forma Tm2
Compounds inhibiting eukaryotic elongation factor 2 kinase activityBDB
Longevica Pharmaceuticals
Benzimidazole derivatives as antihistamine agentsBDB
Faes Farma
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationBDB
Viiv Healthcare UK (NO.5)
Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor.BDB
Jamia Hamdard (Hamdard University)
Perfluoro-tert-butyl Homoserine Is a Helix-Promoting, Highly Fluorinated, NMR-Sensitive Aliphatic Amino Acid: Detection of the Estrogen Receptor·Coactivator Protein-Protein Interaction by (19)F NMR.BDB
University of Delaware
NMDA receptor antagonists for neuroprotectionBDB
Emory University
TRICYCLIC DERIVATIVES AND RELATED USESBDB
Moma Therapeutics
Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative design.BDB
Agouron Pharmaceuticals
Identification of 7-phenylaminothieno- [3,2-b]pyridine-6-carbonitriles as a new class of Src kinase inhibitors.BDB
Wyeth Research
Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4.BDB
Pfizer